Journal of Cellular and Molecular Pharmacology
Open Access

Apoptosis; Programmed cell death; Intrinsic pathway; Extrinsic pathway; Cancer; Neurodegenerative diseases; Bcl-2; Caspases; Cell survival; Therapeutic interventions

Introduction

Apoptosis, often referred to as programmed cell death, is a fundamental cellular process that plays an essential role in the maintenance of cellular homeostasis, development, and immune system function. Unlike necrosis, which results from acute cellular injury and often leads to inflammation, apoptosis is a controlled and regulated process that ensures the elimination of damaged, infected [1], or unnecessary cells in a manner that does not provoke an inflammatory response. This delicate balance between cell survival and cell death is crucial for normal physiological processes such as embryogenesis, immune response, tissue regeneration, and the maintenance of tissue integrity.

At its core, apoptosis involves a series of tightly regulated biochemical events that culminate in characteristic morphological changes such as cell shrinkage, membrane blebbing, chromatin condensation, and DNA fragmentation [2]. These events are controlled by a complex network of signaling pathways that integrate both extracellular and intracellular cues. Dysregulation of apoptosis is associated with a variety of diseases, including cancer, where excessive survival of cells occurs, and neurodegenerative diseases, where excessive cell death leads to tissue degeneration. Understanding the mechanisms of apoptosis is therefore critical for developing therapeutic strategies aimed at manipulating cell death pathways to treat diseases.

Mechanisms of Apoptosis

Apoptosis is typically initiated through two main signaling pathways: the intrinsic pathway and the extrinsic pathway. These pathways converge on a final common pathway involving the activation of caspases, a family of proteases that orchestrate the cellular dismantling during apoptosis.

Intrinsic pathway (Mitochondrial Pathway): The intrinsic pathway is initiated by intracellular signals that arise in response to cellular stress, such as DNA damage, oxidative stress, or lack of survival signals. This pathway is primarily regulated by the mitochondria [3], which act as the central regulators of cell death. Key players in this pathway are members of the Bcl-2 family of proteins, which control mitochondrial outer membrane permeabilization (MOMP).

The Bcl-2 family proteins are divided into pro-apoptotic (e.g., Bax, Bak) and anti-apoptotic (e.g., Bcl-2, Bcl-xL) members. In response to stress signals, pro-apoptotic proteins such as Bax and Bak oligomerize and translocate to the mitochondrial membrane, where they induce MOMP. This leads to the release of cytochrome c from the mitochondria into the cytoplasm. Once cytochrome c is released, it binds to apoptotic protease activating factor 1 (Apaf-1) and forms a complex known as the apoptosome. The apoptosome activates caspase-9, which in turn activates downstream effector caspases, such as caspase-3, resulting in cellular demolition.

Extrinsic Pathway (Death Receptor Pathway): The extrinsic pathway is initiated by the binding of extracellular death ligands to specific cell surface receptors known as death receptors, which belong to the tumor necrosis factor [4] (TNF) receptor family. The most well-studied death receptors are Fas (CD95), TNF receptor 1 (TNFR1), and TRAIL receptors.

Upon ligand binding, death receptors recruit adapter proteins, such as Fas-associated death domain (FADD), which in turn activate caspase-8. Caspase-8 then activates downstream effector caspases, such as caspase-3, leading to the execution of apoptosis. In certain cases, caspase-8 can also cleave the BH3-only protein Bid, which then translocates to the mitochondria and triggers the intrinsic pathway by activating Bax/Bak, further amplifying apoptosis.

Crosstalk between pathways: While the intrinsic and extrinsic pathways are distinct, they often cross-communicate to amplify or modulate the apoptotic response. For example, caspase-8 can initiate mitochondrial damage via the cleavage of Bid, which links the extrinsic pathway to the intrinsic pathway. This interplay between pathways ensures a robust and coordinated response to cellular stress.

Regulation of Apoptosis

The regulation of apoptosis is critical to its role in health and disease. Several key proteins and signaling molecules are involved in controlling whether [5] a cell undergoes apoptosis or survives:

Bcl-2 family proteins: The balance between pro-apoptotic and anti-apoptotic Bcl-2 family members plays a central role in regulating mitochondrial membrane integrity. Anti-apoptotic proteins such as Bcl-2 and Bcl-xL inhibit MOMP and prevent the release of cytochrome c, while pro-apoptotic proteins like Bax and Bak promote MOMP and apoptosis. This balance is critical for determining cell fate in response to stress signals.

Caspases: Caspases are cysteine proteases that act as the executioners of apoptosis. They are initially synthesized as inactive zymogens and are activated by upstream signaling events. Caspase-8 and caspase-9 are initiator caspases that activate effector caspases, such as caspase-3, which cleave a wide variety of cellular substrates, leading to the characteristic morphological changes of apoptosis.

Survival signals and inhibitors: In addition to pro-apoptotic signals, cells also receive survival signals, such as those mediated by growth factors and the phosphoinositide 3-kinase (PI3K)/Akt pathway. These signals can suppress apoptosis by inhibiting the activation of pro-apoptotic proteins or by promoting the expression of anti-apoptotic proteins.

In cancer cells [6], alterations in apoptosis regulation, such as overexpression of anti-apoptotic proteins or mutations in apoptotic regulators, contribute to uncontrolled cell survival and tumorigenesis. Conversely, in neurodegenerative diseases, excessive or unregulated apoptosis leads to the progressive loss of neurons and tissue damage.

Apoptosis in Disease

Dysregulation of apoptosis is a [7] hallmark of many diseases, with both excessive cell death and insufficient cell death contributing to pathology:

Cancer: In cancer, cells often evade apoptosis through mutations in the apoptotic machinery, allowing them to survive despite DNA damage or oncogenic stress. Overexpression of anti-apoptotic proteins (e.g., Bcl-2) or mutations in tumor suppressor genes like p53 are common in cancer cells, making apoptosis-resistant tumors more difficult to treat.

Neurodegenerative diseases: Excessive apoptosis is a key feature of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease [8]. In these conditions, neurons undergo premature death [9], contributing to cognitive decline and motor dysfunction. Targeting the apoptotic pathways in these diseases offers potential therapeutic strategies aimed at protecting neurons from excessive cell death.

Autoimmune diseases: Insufficient apoptosis can contribute to autoimmune diseases, where the failure to eliminate autoreactive immune cells leads to chronic inflammation and tissue damage. In diseases like lupus, inappropriate survival of self-reactive T cells or B cells can drive pathogenesis.

Therapeutic Implications

Given the central role of apoptosis in disease, modulating apoptotic pathways holds significant therapeutic potential. For cancer, therapies aimed at reactivating apoptosis in tumor cells, such as BH3-mimetic drugs that inhibit anti-apoptotic Bcl-2 proteins, are under investigation [10]. Conversely, in neurodegenerative diseases, therapies that inhibit excessive apoptosis could help preserve neurons and slow disease progression.

Conclusion

Apoptosis is a crucial process that governs cell survival and death, playing an essential role in development, tissue homeostasis, and immunity. The mechanisms regulating apoptosis are complex and involve intricate signaling networks. Dysregulation of apoptosis contributes to various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. By understanding the molecular pathways involved in apoptosis, novel therapeutic strategies can be developed to manipulate cell death pathways for disease treatment, offering potential benefits in personalized medicine.

1. Siegel RL, Mille KD, Fuchs HE (2021) Cancer statistics CA Cancer. J Clin 71: 7-33.

Indexed at, Google Scholar, Crossref

2. Swami Sadha Shiva Tirtha (2005) The ayurveda encyclopedia Ayurveda Holistic Center Press.

Indexed at, Google Scholar, Crossref

3. Dhuha Al–kazzaz (2012) framework for adaptation in shape grammars. Des Stud 33: 342-356.

Indexed at, Google Scholar, Crossref

4. Bernard Cache (1995) Earth Moves the Furnishing of Territories. The MIT Press Cambridge.

Indexed at, Google Scholar, Crossref

5. Hosokawa T,Kikuchi Y, Nikoh N (2006) Strict host-symbiont cospeciation and reductive genome evolution in insect gut bacteria. PLoS Biol4.

Indexed at, Google Scholar, Crossref

6. Canfora EE,Jocken JW,Black EE (2015) Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinal 11: 577-591.

Indexed at, Google Scholar, Crossref

7. Alder JD, Daugherty N, Harris ON (1989) Phagocytosis of Treponema pallidum pertenue by hamster macrophages on membrane filters. J  Infect Dis 160: 289-297.

Indexed at, Google Scholar, Crossref

8. Alderete JF, Baseman JB (1986) Surface-associated host proteins on virulent Treponema pallidum. Infect Immun 26: 1048-1105.

Indexed at, Google Scholar, Crossref

9. Granild JB (2015) Predictors for early diagnosis of cerebral palsy from national registry. dataDev Med Child Neuro 57: 931-935.

Indexed at, Google Scholar, Crossref

10. Graf T,Felser C (2011) Simple rules for the understanding of Heusler compound sprog. Solid State Chem39:1-50.

Indexed at, Google Scholar, Crossref